Abstract
BackgroundTargeting mutation-associated neoantigens (MANAs) is a highly-cancer specific strategy to selectively eliminate cells harboring common driver mutations in genes encoding intracellular proteins such as Ras and p53.1, 2 T cell-engaging...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have